Tag: DCGI

कोवैक्सीन के तीसरे चरण का डेटा किया गया पेश, डब्लूएचओ कर सकता है बैठक

भारत बायोटेक ने ड्रग कंट्रोलर जनरल ऑफ इंडिया को कोवैक्सीन के तीसरे चरण के परीक्षण के परिणाम का डेटा दिया है. इसी के चलते 22 जून को ड्रग रेगुलेटर की विषय विशेषज्ञ समिति के साथ नतीजों को लेकर बैठक होने की उम्मीद है. वहीं बुधवार को हैदराबाद स्थित भारत बायोटेक भी विश्व स्वास्थ्य संगठन के […]

Read More

Bharat Biotech has submitted Covaxin’s Phase III trial data to DCGI: Govt sources – ET HealthWorld

The Hyderabad-based Covid vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to the Drugs Controller General of India (DCGI) over the weekend, according to government sources. “We have received the data from the phase III trials,” a senior government official confirmed. Bharat Biotech’s Covaxin is one of the […]

Read More

CSIR to start clinical trials of Colchicine on Covid patients – ET HealthWorld

(PTI Photo/Manvender Vashist) The Council of Scientific and Industrial Research (CSIR) will undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine for the treatment of Covid-19 patients. Colchicine is used for treating gout and related inflammatory conditions. The drug is expected to be an important therapeutic intervention for […]

Read More

Biophore seeks DCGI emergency use approval of Aviptadil for Covid-19 – ET HealthWorld

New Delhi: Biophore India Pharmaceuticals on Friday announced that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19. Biophore has successfully developed Aviptadil, a synthetic form of Vasoactive Intestinal Peptide (VIP) for rapid Covid-19 clinical recovery and is backward […]

Read More

AIIMS Delhi to start screening children for Covaxin trials from Monday – ET HealthWorld

The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigenous home-grown Covid-19 vaccine, Bharat Biotech‘s Covaxin, from Monday, sources said. AIIMS Delhi will be starting clinical trials after AIIMS Patna which started the trials recently on children aged between 12 and 18 years old. After getting permission […]

Read More

Zydus Cadila, gets permission for clinical trials of antibodies cocktail to treat Covid-19: Sources – ET HealthWorld

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of Covid-19 has been given permission to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO), according to sources. “SEC gives a recommendation for the Phase I […]

Read More

Serum Institute of India seeks DCGI’s nod to manufacture Covid vaccine Sputnik V – ET HealthWorld

New Delhi: The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V Covid-19 vaccine for examination, test and analysis at its licensed Hadapsar facility in Pune, official sources said on Thursday. The Pune-based firm has collaborated with the Gamaleya Research Institute of […]

Read More

After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources – ET HealthWorld

New Delhi: Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their Covid-19 jabs in India, the Serum Institute of India (SII) has also sought protection against liabilities, sources said on Thursday. “Not just Serum Institute of India, all the vaccine companies should get indemnity protection against liabilities if foreign […]

Read More

Bihar: Covaxin trials on children begin at Patna’s AIIMS – ET HealthWorld

Patna: Patna’s All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for the Covid-19 vaccine manufactured by the Bharat Biotech, Covaxin. Covaxin received the Drugs Controller General of India (DCGI) nod to conduct clinical trials in children on May 11. VK Paul, Member (Health), Niti Aayog had earlier said, “Covaxin has been […]

Read More